Consonance Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-39,697
Closed -$658K 44
2020
Q4
$658K Buy
+39,697
New +$658K 0.06% 37